Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock

Surgery

Volumn 121, Issue 5, 1997, Pages 493-500

  Schurr, Michael J ^a   Fabian, Timothy C ^b   Croce, Martin A ^b   Geraci, Stephen A ^b   Proctor, Kenneth G ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APAFANT; LIPOPOLYSACCHARIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FLUID THERAPY; HEART INDEX; MORTALITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SWINE; TISSUE OXYGENATION; TRAUMATIC SHOCK;

EID: 0030918618     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90102-1     Document Type: Article

References (25)

1. Kaminski PM, Proctor KG. Extracellular and intracellular actions of adenosine and related compounds in the reperfused rat intestine. Cire Res 1992;71:720-31.
2. Schmeling DJ, Cary MG, Oldham KT, Guice KS, Hinshaw DB. Evidence for neutrophil related lung injury following intestinal ischemia reperfusion injury. Surgery 1989;106:195-203.
3. Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Neutrophil and nonneutrophil mediated injury in intestinal ischemia-reperfusion. Ann Surg 1993;218:444-53.
4. Goldman G, Welbourn R, Klausner JM, Kobzik L, Valeri CR, Shepro D, et al., Mast cells and leukotrienes mediate neutrophil Sequestration and lung edema after remote ischemia in rodents. Surgery 1992;112:575-86.
5. Lindsay TF, Hill J, Ortiz F, Rudolph A, Valeri CR, Hechtman HB, et al. Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg 1992;216:677-83.
6. Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL. Inhibition of CD-18 dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990;108:206-12.
7. Vedder NB, Fouty BW, Winn RK, Harlan JM, Rice CL. Role of neutrophils in generalized reperfusion injury associated with resuscitation from shock. Surgery 1989;106:509-16.
8. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors KE, Harlan JM. A monoclonal antibody to the adherence-promoting leucocyte glycoprotein, CD18, reduced organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988;81:939-44.
9. Benton LD, Khan M, Greco RS. Integrins, adhesion molecules, and surgical research. Surg Gynecol Obstet 1993;177:311-27.
10. Friese RS, Rehring TF, Wollmering M, Moore EE, Ketch L, Banerjee A, et al. Trauma primes cells: editorial review. Shock 1994;1:388-94.
11. Fabian TC, Croce MA, Stewart RM, Dockter ME, Proctor KG. Neutrophil CD18 expression after traumatic shock and endotoxin challenge. Ann Surg 1994;220:552-63.
12. Anderson BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991;172:415-24.
13. Gay JC. Mechanism and regulation of neutrophil priming by platelet-activating factor. J Cell Physiol 1993;156:189-97.
14. Read RA, Moore EE, Moore FA, Carl VS, Banerjee A. Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11B adhesion. Surgery 1993;- 111:308-13.
15. Siebeck M, Weipert J, Keser C, Kohl J, Spannagl M, Machleidt W, et al. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine. J Trauma 1991;31:942-50.
16. Stewart RM, Fabian TC, Fabian MJ, Trenthem LL, Pritchard FE, Croce MA, et al. Gastric and extragastric actions of the histamine antagonist ranitidine during post traumatic sepsis. Surgery 1995;118:63-72.
17. McGinty MP, Stewart RM, Fabian MJ, Fabian TC, Proctor KG. Gamma scintigraphy and early hepatocellular dysfunction during post traumatic sepsis. Surgery 1994;116:535-43.
18. Schurr MJ, Fabian TC, Croce MA, Varnavas LE, Proctor KG. Dehydroepiandrosterone, an endogenous immune modulator, after traumatic shock. Shock 1997;7:55-9.
19. Meyer J, Cox CS, Herndon DN, Nakzawa H, Lentz CW, Traber LD, et al. Heparin in experimental hyperdynamic sepsis. Crit Care Med 1993;21:84-9.
20. Rana MW, Singh G, Wang P, Ayala A, Zhou M, Chaudry IH. Protective effects of preheparinization on the microvasculature during and after hemorrhagic shock. J Trauma 1992;32:420-6.
21. Olson NC, Kruse-Elliott KT, Johnson LW. Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor. Prostaglandins Leukot Essent Fatty Acids 1993;49:549-59.
22. Mozes T, Heiligers JP, Zijlstra FJ, Ben-Efraim S, Saxena PR, Bonta IL. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. J Lipid Mediat 1991;4:309-25.
23. Sawa Y, Schaper J, Roth M, Nagasawa K, Ballagi G, Bleese N, et al. Platelet-activating factor plays an important role in reperfusion injury in myocardium: efficacy of platelet-activating factor receptor antagonist (CV-3988) as compared with leukocyte-depleted reperfusion. J Thorac Cardiovasc Surg 1994;108:953-9.
24. Montrucchio G, Alloatti G, Mariano F, et al. Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. Am J Pathol 1993;142:471-80.
25. Ko W, Lang D, Hawes AS, Zelano JA, Isom OW, Krieger KH. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. J Surg Res 1993;55:504-15.